Comparative Study Between Erector Spinae Plane Block Versus Combined Pectoralis and Serratus Interfascial Plane Blocks for Post-operative Analgesia After Thoracic Surgery.
Randomized Controlled Double Blinded Comparative Study Between Erector Spinae Plane Block Versus Combined Pectoralis and Serratus Interfascial Plane Blocks for Post-operative Analgesia After Thoracic Surgery.
1 other identifier
interventional
66
1 country
1
Brief Summary
The aim of this study is to evaluate the effect of combined pectoralis II and serratus interfascial plane blocks in comparison with erector spinae plane block on post-operative analgesia after thoracic surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 28, 2026
CompletedFirst Posted
Study publicly available on registry
October 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
October 2, 2026
November 1, 2025
1.6 years
September 28, 2026
September 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
First analgesic request
The time of first request to analgesia by patient post operative
24 hours
Study Arms (3)
Erector spinae group
ACTIVE COMPARATORSonar guided interfacial plane block deep to erector spinae muscle that targets dorsal and central Rami of spinal nerves
Combined pectoralis and serratus anterior group
ACTIVE COMPARATORSonar guided interfacial plane blocks firstly pectoralis plane block that targets lateral and medial pectoral nerves then serratus anterior plane block that targets lateral branches of intercostal nerves
Controlled group
NO INTERVENTIONThis group doesn't receive any nerve block
Interventions
Patients will be positioned in the lateral position, The thoracic vertebrae spinous process convenient to level of incision (T5-T7:the level which covers thoracic area) will be identified and the transducer will be placed approximately to 2-3 cm lateral to midline ,The needle tip will be advanced until it is located in the interfascial plane deep to the erector spinae muscle group and superior to the transverse process. Once in position, 30 ml bupivacaine 0.25% will be injected under ultrasound guidance. Correct needle-tip position will be confirmed by the presence of linear spread between the transverse process and the presence of linear spread between the transverse process and the erector spinae muscle group.
Serratus anterior plane block will be performed with the patient in the supine position , The probe will be placed in a sagittal position, the mid-axillary region of the thoracic cage. The needle will be advanced with an in-plane technique and 20 ml bupivacaine 0.25% will be injected . PECS block will be performed at the same position. The ultrasound probe will be placed obliquely over the lateral third of the clavicle. the needle will be advanced, in the same plane as the probe, from the medial to lateral direction ,10 ml 0.25% bupivacaine will be injected. Then the needle will be advanced to the fascial plane between the pectoralis minor and serratus anterior muscles, at which point an additional 10 ml 0.25% bupivacaine will be administered.
Eligibility Criteria
You may qualify if:
- body mass index (BMI) from 20 - 35 kg/m2, ASA physical status I\&II
You may not qualify if:
- Patients with signs of active infection or infection at the site of block placement.
- Refusal of consent. History of any motor or sensory deficits as peripheral neuropathy, history of stroke with residual muscle weakness, multiple sclerosis, pre-existing sensory loss as diabetic neuropathy, spinal cord injury, spine abnormalities as kypholordosis.
- Hypersensitivity or allergy to the drugs used for block. Patients with coagulopathy or on anticoagulant therapy. Extended incision not covered by the block (posterior or medial extended incision).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Minya university
Minya, Minya Governorate, 61511, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Aya Sedeek Mostafa
Study Record Dates
First Submitted
September 28, 2026
First Posted
October 2, 2026
Study Start
April 1, 2025
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
October 2, 2026
Record last verified: 2025-11